JOP20210313A1 - مشتقات حلقية غير متجانسة مندمجة - Google Patents
مشتقات حلقية غير متجانسة مندمجةInfo
- Publication number
- JOP20210313A1 JOP20210313A1 JOP/2021/0313A JOP20210313A JOP20210313A1 JO P20210313 A1 JOP20210313 A1 JO P20210313A1 JO P20210313 A JOP20210313 A JO P20210313A JO P20210313 A1 JOP20210313 A1 JO P20210313A1
- Authority
- JO
- Jordan
- Prior art keywords
- fused heterocyclic
- heterocyclic derivatives
- compounds
- preparing
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962853533P | 2019-05-28 | 2019-05-28 | |
| EP19176933 | 2019-05-28 | ||
| CN2020085720 | 2020-04-20 | ||
| PCT/US2020/034643 WO2020243135A1 (en) | 2019-05-28 | 2020-05-27 | Fused heterocyclic derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JOP20210313A1 true JOP20210313A1 (ar) | 2021-11-25 |
Family
ID=71741889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JOP/2021/0313A JOP20210313A1 (ar) | 2019-05-28 | 2021-11-25 | مشتقات حلقية غير متجانسة مندمجة |
Country Status (19)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022116999A1 (en) * | 2020-12-02 | 2022-06-09 | Janssen Sciences Ireland Unlimited Company | Fused heterocyclic derivatives and their use in the treatment of hbv infection |
| WO2022116998A1 (en) * | 2020-12-02 | 2022-06-09 | Janssen Sciences Ireland Unlimited Company | Fused heterocyclic derivatives as hbv inhibitors |
| TW202237617A (zh) * | 2020-12-02 | 2022-10-01 | 愛爾蘭商健生科學愛爾蘭無限公司 | 稠合雜環衍生物 |
| AR126049A1 (es) | 2021-06-02 | 2023-09-06 | Janssen Sciences Ireland Unlimited Co | Derivados heterocíclicos condensados |
| CA3218641A1 (en) * | 2021-06-02 | 2022-12-08 | Chunliang Lu | Fused heterocyclic derivatives |
| WO2024114709A1 (en) * | 2022-12-01 | 2024-06-06 | Janssen Sciences Ireland Unlimited Company | A crystal form of a fused heterocycle derivative compound |
| WO2024140851A1 (zh) * | 2022-12-28 | 2024-07-04 | 上海维申医药有限公司 | 一类Toll样受体抑制剂及其制备和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2993174A1 (en) * | 2014-09-08 | 2016-03-09 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH | Pyrazolopyridine derivatives and their use in therapy |
| WO2016109689A2 (en) * | 2014-12-30 | 2016-07-07 | Novira Therapeutics, Inc. | Derivatives and methods of treating hepatitis b infections |
| CA3029566A1 (en) * | 2016-06-29 | 2018-01-04 | Novira Therapeutics, Inc. | Diazepinone derivatives and their use in the treatment of hepatitis b infections |
| TW201806956A (zh) * | 2016-06-29 | 2018-03-01 | 諾維拉治療公司 | 二氮呯酮衍生物及治療b型肝炎感染之方法 |
| US20220306647A1 (en) * | 2019-04-30 | 2022-09-29 | Aicuris Gmbh & Co. Kg | Novel indole-2-carboxamides active against the hepatitus b virus (hbv) |
-
2020
- 2020-05-27 CR CR20210666A patent/CR20210666A/es unknown
- 2020-05-27 MX MX2021014575A patent/MX2021014575A/es unknown
- 2020-05-27 JP JP2021570274A patent/JP2022535734A/ja active Pending
- 2020-05-27 CA CA3138168A patent/CA3138168A1/en active Pending
- 2020-05-27 BR BR112021022889A patent/BR112021022889A8/pt unknown
- 2020-05-27 MA MA056043A patent/MA56043A/fr unknown
- 2020-05-27 KR KR1020217042210A patent/KR20220012913A/ko not_active Withdrawn
- 2020-05-27 WO PCT/US2020/034643 patent/WO2020243135A1/en not_active Ceased
- 2020-05-27 AU AU2020285718A patent/AU2020285718A1/en not_active Abandoned
- 2020-05-27 PE PE2021001959A patent/PE20220767A1/es unknown
- 2020-05-27 PH PH1/2021/552974A patent/PH12021552974A1/en unknown
- 2020-05-27 CN CN202080039617.8A patent/CN113906028A/zh active Pending
- 2020-05-27 SG SG11202113167QA patent/SG11202113167QA/en unknown
- 2020-05-27 EP EP20744199.9A patent/EP3976617B1/en active Active
-
2021
- 2021-11-05 DO DO2021000230A patent/DOP2021000230A/es unknown
- 2021-11-23 IL IL288322A patent/IL288322A/en unknown
- 2021-11-25 JO JOP/2021/0313A patent/JOP20210313A1/ar unknown
- 2021-11-26 CL CL2021003155A patent/CL2021003155A1/es unknown
- 2021-12-01 CO CONC2021/0016433A patent/CO2021016433A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3976617B1 (en) | 2025-04-23 |
| CL2021003155A1 (es) | 2022-07-22 |
| MA56043A (fr) | 2022-04-06 |
| MX2021014575A (es) | 2022-05-24 |
| WO2020243135A1 (en) | 2020-12-03 |
| PH12021552974A1 (en) | 2022-07-11 |
| AU2020285718A1 (en) | 2022-02-03 |
| CR20210666A (es) | 2022-03-11 |
| PE20220767A1 (es) | 2022-05-16 |
| EP3976617A1 (en) | 2022-04-06 |
| CO2021016433A2 (es) | 2021-12-10 |
| BR112021022889A8 (pt) | 2024-03-05 |
| DOP2021000230A (es) | 2022-05-31 |
| KR20220012913A (ko) | 2022-02-04 |
| SG11202113167QA (en) | 2021-12-30 |
| CN113906028A (zh) | 2022-01-07 |
| BR112021022889A2 (pt) | 2022-01-04 |
| CA3138168A1 (en) | 2020-12-03 |
| IL288322A (en) | 2022-01-01 |
| JP2022535734A (ja) | 2022-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12021552974A1 (en) | Fused heterocyclic derivatives | |
| GEAP202014690A (en) | Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis b | |
| PH12016501394A1 (en) | Compounds for treating patients with ros1 mutant cancer cells | |
| PH12019501034A1 (en) | New anthelmintic quinoline-3-carboxamide derivatives | |
| ZA202201499B (en) | Dual atm and dna-pk inhibitors for use in anti-tumor therapy | |
| PH12020500257A1 (en) | Quinoline derivatives for treating infections with helminths | |
| IL286210A (en) | Compressed ring pyrimidine history for use in the treatment of hbv infection or diseases caused by hbv | |
| MX391655B (es) | Derivado de oxopicolinamida, metodo de preparacion y uso farmaceutico del mismo | |
| MX2022011029A (es) | Compuestos de arilo, heteroarilo y heterociclicos para el tratamiento de trastornos medicos. | |
| PH12020551891A1 (en) | New quinoline derivatives | |
| CR20190595A (es) | Nuevos derivados de azaquinolina | |
| MX2009010059A (es) | Derivados de quinolina para el tratamiento de enfermedades inflamatorias. | |
| GEP201606560B (en) | Macrocyclic derivatives for the treatment of proliferative diseases | |
| PH12019502365A1 (en) | New bicyclic pyrazole derivatives | |
| EA201591541A1 (ru) | Ингибиторы бета-секретазы 1 (bace 1) | |
| ZA202003281B (en) | Heterocycle substituted pyridine derivative antifungal agents | |
| WO2022116997A8 (en) | Fused heterocyclic derivatives and their use in the treatment of hbv infection | |
| MX380301B (es) | Prevención o tratamiento de enfermedades urinarias o gotosas. | |
| MX2021014581A (es) | Derivados heterociclicos condensados. | |
| MX2021014576A (es) | Derivados heterociclicos condensados como agentes antivirales. | |
| LT3759113T (lt) | 10-(di(fenil)metil)-4-hidroksi-8,9,9a,10-tetrahidro-7h-pirolo[1',2':4,5] pirazino[1,2-b]piridazin-3,5-diono dariniai ir susiję junginiai kaip ortomiksoviruso replikacijos inhibitoriai, skirti gripo gydymui | |
| SG11201901617PA (en) | Azole compound ophthalmic preparation | |
| MX2022006489A (es) | Derivado de anillo de piridina fusionado, metodo de preparacion y usos farmaceuticos del mismo. | |
| WO2020055368A3 (en) | Use of terpernic coumarin derivatives for use in treating viral diseases | |
| ECSP21092791A (es) | Derivados heterocíclicos condensados |